Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolin Bloch

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Nature Immunology|May 20, 2015
Intrinsic host restrictions to HIV-1 and mechanisms of viral escapeViviana Simon, Nicolin Bloch, Nathaniel R Landau
Retrovirology|December 2, 2016
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytesHenning Hofmann, Bénédicte Vanwalscappel, Nicolin Bloch, et al.
Plos One|March 4, 2014
SAMHD1 restricts HIV-1 replication and regulates interferon production in mouse myeloid cellsRuonan Zhang, Nicolin Bloch, Laura A Nguyen, et al.
AIDS Research and Human Retroviruses|August 9, 2013
HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by VpxNicolin Bloch, Meagan O'Brien, Thomas D Norton, et al.
The Journal of Biological Chemistry|December 7, 2016
A Highly Active Isoform of Lentivirus Restriction Factor SAMHD1 in MouseNicolin Bloch, Sabine Gläsker, Poojitha Sitaram, et al.
Journal of Virology|September 14, 2012
The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleusHenning Hofmann, Eric C Logue, Nicolin Bloch, et al.
Plos One|May 16, 2014
A DNA sequence recognition loop on APOBEC3A controls substrate specificityEric C Logue, Nicolin Bloch, Erica Dhuey, et al.
The Journal of Biological Chemistry|March 26, 2013
Novel yeast-based strategy unveils antagonist binding regions on the nuclear xenobiotic receptor PXRHao Li, Matthew R Redinbo, Madhukumar Venkatesh, et al.
Retrovirology|March 19, 2013
Restriction of diverse retroviruses by SAMHD1Thomas Gramberg, Tanja Kahle, Nicolin Bloch, et al.
The AAPS Journal|June 21, 2022
Interference in a Neutralizing Antibody Assay for Odronextamab, a CD20xCD3 Bispecific mAb, from Prior Rituximab Therapy and Possible Mitigation StrategySusan C Irvin, Amanda D'Orvilliers, Nicolin Bloch, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nature Immunology|May 20, 2015
Intrinsic host restrictions to HIV-1 and mechanisms of viral escapeViviana Simon, Nicolin Bloch, Nathaniel R Landau
Retrovirology|December 2, 2016
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytesHenning Hofmann, Bénédicte Vanwalscappel, Nicolin Bloch, et al.
Plos One|March 4, 2014
SAMHD1 restricts HIV-1 replication and regulates interferon production in mouse myeloid cellsRuonan Zhang, Nicolin Bloch, Laura A Nguyen, et al.
AIDS Research and Human Retroviruses|August 9, 2013
HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by VpxNicolin Bloch, Meagan O'Brien, Thomas D Norton, et al.
The Journal of Biological Chemistry|December 7, 2016
A Highly Active Isoform of Lentivirus Restriction Factor SAMHD1 in MouseNicolin Bloch, Sabine Gläsker, Poojitha Sitaram, et al.
Journal of Virology|September 14, 2012
The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleusHenning Hofmann, Eric C Logue, Nicolin Bloch, et al.
Plos One|May 16, 2014
A DNA sequence recognition loop on APOBEC3A controls substrate specificityEric C Logue, Nicolin Bloch, Erica Dhuey, et al.
The Journal of Biological Chemistry|March 26, 2013
Novel yeast-based strategy unveils antagonist binding regions on the nuclear xenobiotic receptor PXRHao Li, Matthew R Redinbo, Madhukumar Venkatesh, et al.
Retrovirology|March 19, 2013
Restriction of diverse retroviruses by SAMHD1Thomas Gramberg, Tanja Kahle, Nicolin Bloch, et al.
The AAPS Journal|June 21, 2022
Interference in a Neutralizing Antibody Assay for Odronextamab, a CD20xCD3 Bispecific mAb, from Prior Rituximab Therapy and Possible Mitigation StrategySusan C Irvin, Amanda D'Orvilliers, Nicolin Bloch, et al.
Pageof 2